bioMérieux

bioMérieux, the global in vitro diagnostics company, is the manufacturer of the BIOFIRE® SPOTFIRE® System, an advanced molecular testing platform designed for urgent care. SPOTFIRE provides rapid, syndromic infectious disease results using FDA‑cleared panels that identify a broad range of likely pathogens in about 15 minutes. With a simple, CLIA‑waived design, minimal hands‑on steps, and seamless workflow integration, SPOTFIRE delivers fast, actionable results to support confident and timely clinical decision‑making.